Accounts Payable, Current of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Accounts Payable, Current for the quarter ending 31 Dec 2024 was $276,125, a 49% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$276,125	+$90,691	+49%	31 Dec 2024	20-F	13 Jun 2025	2024	FY
Q4 2023	$185,434	-$565,701	-75%	31 Dec 2023	20-F/A	23 Sep 2025	2023	FY
Q4 2022	$751,135	+$639,439	+572%	31 Dec 2022	20-F	15 May 2023	2022	FY
Q4 2021	$111,696	+$111,573		31 Dec 2021	20-F	15 May 2023	2022	FY
Q4 2020	$123^*			31 Dec 2020	20-F	15 May 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.